Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI

被引:8
|
作者
Zhang, Yan-Nan [1 ]
Lu, Zhen-Guo [1 ]
Wang, Shuai-Dong [2 ]
Lu, Xin [1 ]
Zhu, Lei-Lei [1 ]
Yang, Xu [1 ]
Fu, Li-Ping [1 ]
Zhao, Jun [3 ]
Wang, Hai-Feng [2 ]
Xiang, Zuo-Lin [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Radiat Oncol, Shanghai 200120, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Urol, Shanghai 200120, Peoples R China
[3] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Nucl Med, Shanghai 200120, Peoples R China
基金
中国国家自然科学基金;
关键词
Prostate cancer; Gross tumor volume; Radiotherapy; PSMA PET; MRI; HYBRID PET/MRI; PET/CT; VALIDATION; PSMA; MRI; RECURRENCE; GUIDELINES; LESIONS;
D O I
10.1186/s40644-022-00475-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background We aimed to assess the clinical value of F-18-PSMA-1007 and Ga-68-PSMA-11 PET/MRI in the gross tumor volume (GTV) delineation of radiotherapy for prostate cancer (PCa). Methods Sixty-nine patients were retrospectively enrolled (57 in the F-18 subgroup and 12 in the Ga-68 subgroup). Three physicians delineated the GTV and tumor length by the visual method and threshold method with thresholds of 30%, 40%, 50%, and 60% SUVmax. The volume correlation and differences in GTVs were assessed. The dice similarity coefficient (DSC) was applied to estimate the spatial overlap between GTVs. For 51 patients undergoing radical prostatectomy, the tumor length (Lpath) of the maximum area was measured, and compared with the longest tumor length obtained based on the images (L-MRI, L-PET/MRI, L-PET, L-PET30%, L-PET40%, L-PET50%, L-PET60%) to determine the best delineation method. Results In the F-18 subgroup, (1) GTV-PET/MRI (p < 0.001) was significantly different from the reference GTV-MRI. DSC between them was > 0.7. (2) GTV-MRI (R-2 = 0.462, p < 0.05) was the influencing factor of DSC. In the Ga-68 subgroup, (1) GTV-PET/MRI (p < 0.05) was significantly different from the reference GTV-MRI. DSC between them was > 0.7. (2) There was a significant correlation between GTV-MRI (r = 0.580, p < 0.05) and DSC. The longest tumor length measured by PET/MRI was in good agreement with that measured by histopathological analysis in both subgroups. Conclusion It is feasible to visually delineate GTV on PSMA PET/MRI in PCa radiotherapy, and we emphasize the utility of PET/MRI fusion images in GTV delineation. In addition, the overlap degree was the highest between GTV-MRI and GTV-PET/MRI, and it increased with increasing volume.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI
    Yan-Nan Zhang
    Zhen-Guo Lu
    Shuai-Dong Wang
    Xin Lu
    Lei-Lei Zhu
    Xu Yang
    Li-Ping Fu
    Jun Zhao
    Hai-Feng Wang
    Zuo-Lin Xiang
    Cancer Imaging, 22
  • [2] 68Ga-PSMA-11 PET, 18F-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer Variability
    Draulans, Cedric
    Pos, Floris
    Smeenk, Robert J.
    Kerkmeijer, Linda
    Vogel, Wouter V.
    Nagarajah, James
    Janssen, Marcel
    Mai, Cindy
    Heijmink, Stijn
    van der Leest, Marloes
    Zamecnik, Patrik
    Oyen, Raymond
    Isebaert, Sofie
    Maes, Frederik
    Joniau, Steven
    Kunze-Busch, Martina
    De Roover, Robin
    Defraene, Gilles
    van der Heide, Uulke A.
    Goffin, Karolien
    Haustermans, Karin
    PRACTICAL RADIATION ONCOLOGY, 2021, 11 (03) : 202 - 211
  • [3] Optimal 68Ga-PSMA-11 and 18F-PSMA-1007 PET window levelling for gross tumour volume delineation in primary prostate cancer
    Goffin, K.
    Draulans, C.
    De Roover, R.
    van der Heide, U. A.
    Kerkmeijer, L.
    Smeenk, R. J.
    Pos, F.
    Vogel, W. V.
    Nagarajah, J.
    Janssen, M.
    Isebaert, S.
    Maes, F.
    Mai, C.
    Oyen, R.
    Joniau, S.
    Kunze-Busch, M.
    Haustermans, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S404 - S405
  • [4] 68Ga-PSMA-11-PET, 18F-PSMA-1007-PET and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Inter-tracer Variability
    Draulans, C.
    Pos, F. J.
    Smeenk, R. J.
    Kerkmeijer, L.
    Vogel, W.
    Nagarajah, J.
    Janssen, M.
    Mai, C.
    Heijmink, S.
    van der Leest, M.
    Zamecnik, P.
    Isebaert, S.
    Maes, F.
    Joniau, S.
    Kunze-Busch, M.
    De Roover, R.
    Defraene, G.
    van der Heide, U.
    Goffin, K.
    Haustermans, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E878 - E878
  • [5] Serial 18F-PSMA-1007 PET/CT imaging: A comparative study with 68Ga-PSMA-11
    Sharma, P.
    Watts, A.
    Singh, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S114 - S115
  • [6] Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
    Jannusch, Kai
    Bruckmann, Nils Martin
    Morawitz, Janna
    Boschheidgen, Matthias
    Quick, Harald H.
    Herrmann, Ken
    Fendler, Wolfgang P.
    Umutlu, Lale
    Stuschke, Martin
    Hadaschik, Boris
    Antoch, Gerald
    Schimmoeller, Lars
    Kirchner, Julian
    EUROPEAN RADIOLOGY, 2024, 34 (07) : 4789 - 4800
  • [7] Preliminary comparative study between 18F-PSMA-1007 and 68Ga-PSMA-11 PET/CT in patients with prostate cancer biodistribution and tumor detection
    Chen, Sirong
    Wong, Yuet Hung
    Tsoi, Tung Tung
    Leung, Yim Lung
    Cheng, Kam Chau
    Wong, Ka Nin
    Cheung, William
    Wu, Kwan Kit
    Ho, Chi-Lai
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [8] Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer
    Chandekar, Kunal Ramesh
    Singh, Harmandeep
    Kumar, Rajender
    Kumar, Santosh
    Kakkar, Nandita
    Mittal, Bhagwant Rai
    Singh, Shrawan Kumar
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (01) : E1 - E8
  • [9] Impact of Targeted Molecular Imaging with 18F-PSMA-1007 and 68Ga-PSMA-11 PET/CT in Multimodal Evaluation of Local Recurrence of Prostate Cancer
    Dronka, L.
    Radzina, M.
    Tirane, M.
    Zemniece, L.
    Kalnina, M.
    Roznere, L.
    Briede, I.
    Lietuvietis, V.
    Freimanis, A.
    Vjaters, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S173 - S174
  • [10] 68Ga-PSMA-11 PET/MRI in Primary Intermediate/High-Risk Prostate Cancer
    Park, S.
    Zacharias, C.
    Harrison, C.
    Baratto, L.
    Hatami, N.
    Iagaru, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S709 - S710